Best Healthcare Stocks in India — 2026 Rankings
7 companies AI-ranked by earnings call analysis. 1 with strong growth signals this quarter.
Total Companies
7
Rank 1 (40%+ growth)
1
Rank 2 (20-40% growth)
1
Active Capex
7
Sector Leaderboard
| # | Company | Market Cap | Revenue | Margin | Capex | Fundraise |
|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company | 0 Cr | Rank 1 | Rank 3 | Yes | — |
| 2 | Bristol-Myers Squibb Company | 1.2L Cr | Rank 3 | Rank 3 | Yes | — |
| 3 | Amgen Inc. | 0 Cr | Rank 2 | Rank 3 | Yes | — |
| #4 | Merck & Co., Inc. | 3.0L Cr | Rank 4 | Rank 3 | Yes | — |
| #5 | Abbott Laboratories | 0 Cr | Rank 3 | Rank 3 | Yes | — |
| #6 | Gilead Sciences, Inc. | 0 Cr | Rank 4 | Rank 2 | Yes | — |
| #7 | Merck & Co., Inc. | 0 Cr | Rank 4 | Rank 4 | Yes | — |
Frequently Asked Questions
Which are the best Healthcare stocks in India?
Based on AI analysis of the latest earnings calls, the top Healthcare stocks include Eli Lilly and Company, Bristol-Myers Squibb Company, Amgen Inc., Merck & Co., Inc., Abbott Laboratories. These companies are ranked by revenue growth, margin strength, and capex activity.
How is the Healthcare sector performing in 2026?
The Healthcare sector currently has 7 tracked companies. 1 companies show strong revenue growth above 40%, and 7 companies have active capital expenditure programs, indicating expansion and investment in the sector.
How many Healthcare companies have high growth in 2026?
Out of 7 Healthcare companies tracked, 1 are classified as Rank 1 with over 40% revenue growth, and 1 are Rank 2 with 20-40% growth, based on AI-powered earnings call analysis.